Citigroup’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
32,925
-35,728
-52% -$1.32M ﹤0.01% 2966
2025
Q4
$2.44M Buy
68,653
+54,245
+376% +$1.52M ﹤0.01% 2526
2025
Q3
$207K Sell
14,408
-45,317
-76% -$537K ﹤0.01% 3980
2025
Q2
$429K Sell
59,725
-137,282
-70% -$761K ﹤0.01% 3716
2025
Q1
$1.18M Buy
197,007
+52,553
+36% +$412K ﹤0.01% 3132
2024
Q4
$1.13M Buy
144,454
+76,038
+111% +$758K ﹤0.01% 3273
2024
Q3
$739K Buy
68,416
+29,086
+74% +$283K ﹤0.01% 3485
2024
Q2
$332K Sell
39,330
-560,659
-93% -$4.25M ﹤0.01% 3634
2024
Q1
$4.03M Buy
599,989
+478,138
+392% +$2.96M ﹤0.01% 1876
2023
Q4
$716K Buy
121,851
+39,610
+48% +$304K ﹤0.01% 3113
2023
Q3
$802K Buy
82,241
+2,522
+3% +$29.9K ﹤0.01% 2683
2023
Q2
$944K Sell
79,719
-114,871
-59% -$1.32M ﹤0.01% 2886
2023
Q1
$2.1M Buy
194,590
+50,605
+35% +$647K ﹤0.01% 1992
2022
Q4
$1.66M Sell
143,985
-48,287
-25% -$598K ﹤0.01% 2190
2022
Q3
$2.87M Buy
192,272
+57,268
+42% +$785K ﹤0.01% 1895
2022
Q2
$1.22M Buy
135,004
+1,235
+0.9% +$8.43K ﹤0.01% 2484
2022
Q1
$1M Sell
133,769
-8,229
-6% -$57.3K ﹤0.01% 2947
2021
Q4
$1.22M Sell
141,998
-112,681
-44% -$980K ﹤0.01% 3052
2021
Q3
$2.14M Buy
254,679
+216
+0.1% +$1.66K ﹤0.01% 2490
2021
Q2
$2.06M Sell
254,463
-38,851
-13% -$328K ﹤0.01% 2641
2021
Q1
$2.58M Buy
293,314
+253,048
+628% +$2.44M ﹤0.01% 2323
2020
Q4
$452K Buy
+40,266
New +$442K ﹤0.01% 4295
2020
Q1
Sell
-538
Closed -$2K 7619
2019
Q4
$2K Buy
538
+1
+0.2% +$4 ﹤0.01% 7539
2019
Q3
$3K Hold
537
﹤0.01% 7445
2019
Q2
$6K Sell
537
-888
-62% -$11.8K ﹤0.01% 7429
2019
Q1
$25K Buy
1,425
+326
+30% +$5.57K ﹤0.01% 6830
2018
Q4
$19K Buy
1,099
+855
+350% +$25.3K ﹤0.01% 6895
2018
Q3
$10K Buy
244
+117
+92% +$6.59K ﹤0.01% 7343
2018
Q2
$7K Buy
+127
New +$6.11K ﹤0.01% 7271

Other funds holding COGT